GAIN THERAPEUTICS INC GANX
COM · Common Stock · CUSIP 36269B105
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersBethesda, MD
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 11.9m as of 2021-07-31, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $10.00.
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2021 | 13 |
| Q2 2021 | 15 |
Biggest buyers
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | New | +50.0k |
| Telemetry Investments, L.L.C. | New | +30.3k |
| BlackRock Inc. | New | +11.7k |
| CM Management, LLC | New | +10.0k |
| MILLENNIUM MANAGEMENT LLC | Added | +9.5k |
| Banque Cantonale Vaudoise | New | +3.0k |
| Steward Partners Investment Advisory, LLC | New | +100 |
| Tower Research Capital LLC (TRC) | New | +72 |
| WELLS FARGO & COMPANY/MN | New | +24 |
Biggest sellers
| Granite Point Capital Management, L.P. | Reduced | -69.3k |
| AIGH Capital Management LLC | Sold out | -65.8k |
| JANE STREET GROUP, LLC | Sold out | -22.8k |
| Maven Securities LTD | Sold out | -22.1k |
| Worth Venture Partners, LLC | Sold out | -15.5k |
| MYDA Advisors LLC | Sold out | -14.0k |
| UBS Group AG | Reduced | -2.0k |
Insider purchases and sales in Q2 2021
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2021.
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| GREENLIGHT CAPITAL INC 0.34% of their portfolio | 546.6k $5.5m | Unchanged |
| Granite Point Capital Management, L.P. 0.46% of their portfolio | 155.7k $1.6m | Reduced -69.3k |
| PRELUDE CAPITAL MANAGEMENT, LLC 0.03% of their portfolio | 58.1k $581.0k | Unchanged |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.01% of their portfolio | 50.0k $501.0k | New |
| Telemetry Investments, L.L.C. 0.42% of their portfolio | 30.3k $303.0k | New |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 23.9k $239.0k | Added +9.5k |
| BlackRock Inc. 0.00% of their portfolio | 11.7k $116.0k | New |
| CM Management, LLC 0.07% of their portfolio | 10.0k $100.0k | New |
| UBS Group AG 0.00% of their portfolio | 4.1k $41.0k | Reduced -2.0k |
| Banque Cantonale Vaudoise 0.00% of their portfolio | 3.0k $30.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 800 $8.0k | Unchanged |
| Steward Partners Investment Advisory, LLC 0.00% of their portfolio | 100 $1.0k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 72 $0 | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 24 $0 | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |